Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Altomed Malhotra Platinum Segments

N.º K: K170591 · 2017-06-06

SolicitanteAltomed Limited
Fecha de decisión2017-06-06
Código de productoMML
Comité asesorOP
DecisiónSubstantially Equivalent

Resumen del dispositivo

Altomed Malhotra Platinum Segments is the device name listed in this FDA 510(k) record. The listed applicant is Altomed Limited. It received FDA 510(k) clearance on 2017-06-06 under 510(k) number K170591. The device is classified under product code MML. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Altomed Malhotra Platinum Segments?

Altomed Malhotra Platinum Segments is a medical device that received FDA 510(k) clearance on 2017-06-06. The listed applicant is Altomed Limited. The 510(k) number is K170591.

When did Altomed Malhotra Platinum Segments receive FDA 510(k) clearance?

Altomed Malhotra Platinum Segments received FDA 510(k) clearance on 2017-06-06, under 510(k) number K170591.

Who is the listed applicant for Altomed Malhotra Platinum Segments?

The FDA 510(k) record lists Altomed Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Altomed Malhotra Platinum Segments?

The FDA product code for Altomed Malhotra Platinum Segments is MML.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑